Skip to main content

Overview of Growth Hormone and IGF-I Effects on Intermediary Metabolism and Bone

  • Conference paper
Book cover GHRH, GH, and IGF-I

Part of the book series: Serono Symposia USA ((SERONOSYMP))

  • 87 Accesses

Abstract

The classic actions of GH and IGF-I involve direct and indirect stimulation of cell proliferation and somatic growth. This chapter, however, provides an overview of the nonanabolic and non-growth-promoting actions of GH and IGF-I. This brief overview highlights the issues to be dealt with in depth in the ensuing chapters. For many years growth hormone (GH) has been known to behave as a potent insulin antagonist. Although the mechanism for GH-induced insulin resistance probably involves postreceptor signaling pathways, the cellular site of this interaction remains elusive.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bengtsson B-A. The consequences of growth hormone deficiency in adults. Acta Endocrinol (Copenh) 1993;128:2–5.

    Google Scholar 

  2. Maghnie M, Valtorta A, Moretta A, et al. Diagnosing growth hormone deficiency: the value of short term hypocaloric diet. J Clin Endocrinol Metab 1993;77:1372–8.

    Article  PubMed  CAS  Google Scholar 

  3. Landon J, Greenwood FC, Stamp TCB, Wynn V. The plasma sugar, free fatty acid, cortisol and growth hormone response to insulin, and the com-parison of this procedure with other tests of pituitary and adrenal function; II. In patients with hypothalamic or pituitary dysfunction or anorexia nervosa. J Clin Invest 1966;45:437–49.

    Article  PubMed  CAS  Google Scholar 

  4. Hoffman DM, Kelly JJ, O’Sullivan A, et al. Diagnosis of growth hormone deficiency in adults [Abstract]. 75th annu meet Endocr Soc 1993:224, 696c.

    Google Scholar 

  5. Winer L, Shaw M, Baumann G. Basal plasma growth hormone levels in man: new evidence for rhythmicity of growth hormone secretion. J Clin Endocrinol Metab 1990;70:1678–86.

    Article  PubMed  CAS  Google Scholar 

  6. Clemmons DR, Van Wyk JJ, Ridgway EC, Kliman B, Kjellberg RN, Underwood LE. Evaluation of acromegaly by radio-immunoassay of somatomedinC. N Engl J Med 1979;301:1138–42.

    Article  PubMed  CAS  Google Scholar 

  7. Hartman ML, Veldhuis JD, Johnson ML, et al. Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men. J Clin Endocrinol Metab 1992; 74:757–65.

    Article  PubMed  CAS  Google Scholar 

  8. Umpleby M, Salomon F. Workshop report: protein metabolism and muscles: the effects of growth hormone and growth hormone deficiency. Acta Endocrinol (Copenh) 1993;128:65–6.

    Google Scholar 

  9. Rosen T, Eden S, Larson G, Wilhelmsen L, Bengtsson B-A. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 1993;129:195–200.

    CAS  Google Scholar 

  10. O’Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes Si, Adams JE, Shalet SM. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 1993;76:1344–8.

    Article  PubMed  Google Scholar 

  11. Degerblad M, Elgindy N, Hall K, Hans-Erik S, Thoren M. Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol (Copenh) 1992;126:387–93.

    CAS  Google Scholar 

  12. Binnerts A, Swart GR, Wilson PJH, et al. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol 1992;37:79–87.

    Article  CAS  Google Scholar 

  13. Clemmons DR, Underwood LE. Anabolic and metabolic effects of growth hormone action: role of insulin-like growth factors and growth hormone in reversing catabolic states. Horm Res 1992;38:37–40.

    Article  PubMed  CAS  Google Scholar 

  14. Salomon F, Cuneo RC, Hesp R, Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989;321:1797–803.

    Article  PubMed  CAS  Google Scholar 

  15. Thorner MO, Vance ML, Horvath E, Kovacs K. The anterior pituitary. In: Wilson JD, Foster DW, eds. Williams textbook of endocrinology. 8th ed. Philadelphia: WB Saunders, 1992:221–310.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this paper

Cite this paper

Melmed, S. (1995). Overview of Growth Hormone and IGF-I Effects on Intermediary Metabolism and Bone. In: Blackman, M.R., Roth, J., Harman, S.M., Shapiro, J.R. (eds) GHRH, GH, and IGF-I. Serono Symposia USA. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-0807-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-0807-5_16

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-6908-3

  • Online ISBN: 978-1-4612-0807-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics